Trial intelligence / Profile preview

MitoQ in chronic Hepatitis C

NCT00433108Phase 2Completed

Sponsor
Antipodean Pharmaceuticals, Inc.
Start
Mar 2007
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of mitoquinone in hepatitis C (HCV), sponsored by Antipodean Pharmaceuticals, Inc.. Started Mar 2007; status: completed.

02

Drugs

mitoquinone
03

Conditions

hepatitis C (HCV)

Beyond the preview

Go deeper on NCT00433108.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00433108.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call